Seminars in Hematology
Volume 45, Issue 3 , Pages 176-180 , July 2008

Interpreting the Results of Systematic Reviews

  • Mike Clarke

      Affiliations

    • Corresponding Author InformationAddress correspondence to Mike Clarke, School of Nursing and Midwifery, Trinity College Dublin, 24 D'Olier St, Dublin 2, Ireland.

References 

  1. Childhood ALL Collaborative Group. Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12,000 randomised children. Lancet. 1996;347:1783–1788
  2. Clarke M, Gaynon P, Hann I, Harrison G, Masera G, Peto R, et al. CNS-directed therapy for childhood acute lymphoblastic leukaemia: Childhood ALL Collaborative Group overview of 43 randomized trials. J Clin Oncol. 2003;21:1798–1809
  3. Green H, Paul M, Vidal L, Leibovici L. Prophylaxis for pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database of Systematic Reviews Issue. 2007;3:CD005590
  4. Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG. Epidemiology and reporting characteristics of systematic reviews. PLoS Med. 2007;4:e78
  5. Weingart O, Kober T, Engert A, Diehl V, Djulbegovic B, Glasmacher A, et al. Cochrane Haematological Malignancies Group About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) Issue 2:Art. No.: HAEMATOL. 2006;
  6. El Dib RP, Atallah AN, Andriolo RB. Mapping the Cochrane evidence for decision making in health care. J Eval Clin Pract. 2007;13:689–692
  7. Clarke L, Clarke M, Clarke T. Implications for research from Cochrane reviews. J Health Services Res Policy. 2007;12:101–103
  8. Clarke M. Doing new research? (Don't forget the old: Nobody should do a trial without reviewing what is known). PLoS Med. 2004;1:100–102
  9. Brown P, Brunnhuber K, Chalkidou K, Chalmers I, Clarke M, Fenton M, et al. How to formulate research recommendations. BMJ. 2006;333:804–806
  10. Mulrow C. The medical review article: state of the science. Ann Intern Med. 1987;106:485–488
  11. In:  Khan KS,  ter Riet G,  Glanville J,  Sowden AJ,  Kleijnen J editor. Undertaking Systematic Reviews of Research on Effectiveness. ed 2. York, UK: NHS Centre for Reviews and Dissemination, University of York; 2001;
  12. In:  Higgins JPT,  Green S editor. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6. 2006;updated September http://www.cochrane.org/resources/handbook/hbook.htm(accessed December 6, 2007)
  13. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Lancet. 1999;354:1896–1900
  14. Katrak P, Bialocerkowski AE, Massy-Westropp N, Kumar S, Grimmer KA. A systematic review of the content of critical appraisal tools. BMC Med Res Methodol. 2004;4:22
  15. Oxman AD, Guyatt GH. Validation of an index of the quality of review articles. J Clin Epidemiol. 1991;44:1271–1278
  16. Oxman AD. Checklists for review articles. BMJ. 1994;309:648–651
  17. Shea BJ, Boers M, Grimshaw JM, Hamel CD, Bouter LM. Does updating improve the methodological and reporting quality of systematic reviews?. BMC Med Res Methodol. 2006;6:27
  18. Sacks H, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analyses of randomized controlled trials. N Engl J Med. 1987;316:450–455
  19. Shea B, Moher D, Graham I, Pham B, Tugwell P. A comparison of the quality of Cochrane reviews and systematic reviews published in paper-based journals. Evaluation Health Professions. 2002;25:116–129
  20. Shojania KG, Sampson M, Ansari MT, Doucette S, Moher D. How quickly do systematic reviews go out of date? (A survival analysis). Ann Intern Med. 2007;147:224–233
  21. Hopewell S, Clarke M, Stewart L, Tierney J. Time to publication for results of clinical trials. Cochrane Database of Systematic Reviews. 2007;2:MR000011
  22. Guyatt GH, Sackett DL, Cook DJ Evidence-Based Medicine Working Group. Users' guides to the medical literature, II: How to use an article about therapy or prevention, B: What were the results and will they help me in caring for my patients. JAMA. 1994;271:59–63
  23. Yusuf S, Wittes J, Probstfield J, Tyroler HA. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA. 1991;266:93–98
  24. Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Ann Intern Med. 1992;116:78–84
  25. Counsell CE, Clarke MJ, Slattery J, Sandercock PAG. The miracle of DICE therapy for acute stroke: Fact or fictional product of subgroup analysis?. BMJ. 1994;309:1677–1681
  26. Myeloma Trialists Collaborative Group. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials. J Clin Oncol. 1998;16:3832–3842
  27. Deeks JJ, Altman DG. Effect measures for meta-analysis of trials with binary outcomes. In:  Egger M,  Davey Smith G,  Altman DG editor. Systematic Reviews in Health Care. ed 2. London, UK: BMJ Publishing Group; 2001;p. 313–335
  28. Schulz H, Bohlius J, Skoetz N, Trelle S, Kober T, Reiser M, et al. Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma. Cochrane Database of Systematic Reviews. 2007;4:CD003805

PII: S0037-1963(08)00061-9

doi: 10.1053/j.seminhematol.2008.04.002

Seminars in Hematology
Volume 45, Issue 3 , Pages 176-180 , July 2008

Article Tools